Revvity
Alice Wood is a Scientist II specializing in cell line engineering, currently leading high-impact projects at Revvity since May 2023, where management of teams of up to 20 scientists and regular presentations to stakeholders are key aspects of the role. Previously, at Horizon Discovery from August 2020 to May 2023, Alice designed CRISPR-Cas9 targeting reagents and established a comprehensive training program, which enhanced project capacity and collaboration. Earlier roles included extensive cell culture experience, quality assurance in herbal testing at Pukka Herbs, and laboratory positions focused on cell line development and diagnostic testing. Alice holds a Bachelor of Science degree in Biochemistry from the University of Bristol, obtained in 2017.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com